Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14798
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search